Varian Manufactures Halcyon Radiotherapy Systems in Germany for the First Time

Siemens HealthineersVarian, a Siemens Healthineers company, manufactures the first Halcyon radiotherapy system at its Kemnath site. Siemens Healthineers built a completely new production line at the plant and expanded its research and development team. With the acquisition of Varian, these are once again part of the Siemens Healthineers product portfolio. Systems for the German, European and US markets are manufactured in Kemnath. The first Halcyon from Kemnath goes to Curavid Radiotherapy and Radiology in Lübeck. Siemens Healthineers announced in February 2022 that it would invest EUR 60 million in the Kemnath production site and create 50 new jobs. The expansion of the production to include radiotherapy devices is part of this investment.

"We want to further expand the production of radiotherapy systems in Kemnath and increase the quantities. We also want to increase the vertical integration of the Halcyon system by producing more individual parts here in the plant," said Michael Braunreuther, head of the Kemnath site at Siemens Healthineers. "The expansion of our portfolio here in Kemnath is a further commitment to Germany as a location for innovation."

Radiotherapy is one of the most important methods of modern cancer therapy and is now used in more than half of all cancer treatments. The radiotherapy devices, so-called linear accelerators, are part of the product portfolio of Varian, now a Siemens Healthineers company. Linear accelerators are used both in the outpatient sector and in hospitals for the targeted treatment of cancer. The Halcyon system from Varian is one of the most technically innovative accelerator systems on the market. Siemens Healthineers built another production site for these systems in Kemnath. A second production site is located in Beijing. Until 2012, Siemens Healthineers manufactured radiotherapy systems in Kemnath. Parts of the infrastructure, such as the radiation-proof test cabins, are still available and can be used to test the new Varian systems. The production of radiotherapy systems complements the existing portfolio at the site. The Kemnath plant in the Oberpfalz region was established in 1962. It has grown since then from a purely contract-based manufacturer to a Center of Competence for mechatronics that covers large parts of the Siemens Healthineers product range. The components developed and manufactured in Kemnath include C-arms for angiography systems in addition to tables for MRI units and components for analytical systems used in lab diagnostics. In the future, tables for the TrueBeam radiotherapy system will also be manufactured here.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.

Most Popular Now

500 Patient Images per Second Shared thr…

The image exchange portal, widely known in the NHS as the IEP, is now being used to share as many as 500 images each second - including x-rays, CT, MRI...

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

Using AI to Treat Infections more Accura…

New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...